Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 4;23(17):10123.
doi: 10.3390/ijms231710123.

Tear Biomarkers in Alzheimer's and Parkinson's Diseases, and Multiple Sclerosis: Implications for Diagnosis (Systematic Review)

Affiliations

Tear Biomarkers in Alzheimer's and Parkinson's Diseases, and Multiple Sclerosis: Implications for Diagnosis (Systematic Review)

Angelika Król-Grzymała et al. Int J Mol Sci. .

Abstract

Biological material is one of the most important aspects that allow for the correct diagnosis of the disease, and tears are an interesting subject of research because of the simplicity of collection, as the well as the relation to the components similar to other body fluids. In this review, biomarkers for Alzheimer's disease (AD), Parkinson's disease (PD), and multiple sclerosis (MS) in tears are investigated and analyzed. Records were obtained from the PubMed and Google Scholar databases in a timeline of 2015-2022. The keywords were: tear film/tear biochemistry/tear biomarkers + diseases (AD, PD, or MS). The recent original studies were analyzed, discussed, and biomarkers present in tears that can be used for the diagnosis and management of AD, PD, and MS diseases were shown. α-synTotal and α-synOligo, lactoferrin, norepinephrine, adrenaline, epinephrine, dopamine, α-2-macroglobulin, proteins involved in immune response, lipid metabolism and oxidative stress, apolipoprotein superfamily, and others were shown to be biomarkers in PD. For AD as potential biomarkers, there are: lipocalin-1, lysozyme-C, and lacritin, amyloid proteins, t-Tau, p-Tau; for MS there are: oligoclonal bands, lipids containing choline, free carnitine, acylcarnitines, and some amino acids. Information systematized in this review provides interesting data and new insight to help improve clinical outcomes for patients with neurodegenerative disorders.

Keywords: Alzheimer’s disease; Parkinson’s disease; biomarkers; multiple sclerosis; tears.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Tear composition (created with BioRender.com, accessed on 25 July 2022).
Figure 2
Figure 2
Scheme of literature searching (created with BioRender.com, accessed on 25 July 2022).

References

    1. Chojnowska S., Baran T., Wilińska I., Sienicka P., Cabaj-Wiater I., Knaś M. Human Saliva as a Diagnostic Material. Adv. Med. Sci. 2018;63:185–191. doi: 10.1016/j.advms.2017.11.002. - DOI - PubMed
    1. Woźniak M., Paluszkiewicz C., Kwiatek W.M. Saliva as a Non-Invasive Material for Early Diagnosis. Acta Biochim. Pol. 2019;66:383–388. doi: 10.18388/abp.2019_2762. - DOI - PubMed
    1. Pieragostino D., Lanuti P., Cicalini I., Cufaro M.C., Ciccocioppo F., Ronci M., Simeone P., Onofrj M., van der Pol E., Fontana A., et al. Proteomics Characterization of Extracellular Vesicles Sorted by Flow Cytometry Reveals a Disease-Specific Molecular Cross-Talk from Cerebrospinal Fluid and Tears in Multiple Sclerosis. J. Proteom. 2019;204:103403. doi: 10.1016/j.jprot.2019.103403. - DOI - PubMed
    1. Barmada A., Shippy S.A. Tear Analysis as the next Routine Body Fluid Test. Eye. 2020;34:1731–1733. doi: 10.1038/s41433-020-0930-0. - DOI - PMC - PubMed
    1. Cicalini I., Rossi C., Pieragostino D., Agnifili L., Mastropasqua L., di Ioia M., De Luca G., Onofrj M., Federici L., Del Boccio P. Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid. Int. J. Mol. Sci. 2019;20:1265. doi: 10.3390/ijms20061265. - DOI - PMC - PubMed

Publication types

MeSH terms